BOAA
REGN icon

Bank of Ann Arbor’s Regeneron Pharmaceuticals REGN Stock Holding History

Bank of Ann Arbor’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$242K Buy
+319
New +$241K 0.03% 187

Other funds holding REGN

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $187B AUM 13.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Bank of Ann Arbor's REGN Position: Q3 2026 in Review

Bank of Ann Arbor opened a new position in Regeneron Pharmaceuticals (REGN) in Q3 2026: 319 shares worth $242K. The stake represents 0.03% of the portfolio and ranks #187 among its holdings.

1,212 funds tracked by Wall St. Rank hold REGN as of Q3 2026.

  • Bank of Ann Arbor held 319 shares of Regeneron Pharmaceuticals worth $242K as of Q3 2026.
  • Regeneron Pharmaceuticals was a new Bank of Ann Arbor position in Q3 2026.
  • Regeneron Pharmaceuticals made up 0.03% of Bank of Ann Arbor's portfolio in Q3 2026, its #187 holding.
  • 1,212 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.

Based on Bank of Ann Arbor's 13F filing for Q3 2026, filed 13 Nov 2026.